Javascript must be enabled to continue!
Somatostatin
View through CrossRef
Somatostatin, also known as growth hormone-inhibiting factor (GIF) or somatotropin release-inhibiting factor (SRIF), is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation. Somatostatin can be regarded as secretory pan-inhibitory,because it can inhibit secretion of almost all endocrine and exocrine glands. Somatostatin has 2 active forms (somatostatin-14 and 28), but the short half-life of the hormone was one of the reasons why the native hormone was not feasible for routine clinical practice. Somatostatin analog was synthesized for the first time in 1980-1982 and proved to be more resistant to degradation and more potent than native hormone. There are five somatostatin receptors (SSTR1-5). The genes encoding human SSTR1-5 are located in chromosome 14q13, 17q24, 22q13.1, 20p11.2 and 16p13.3. SSTR expression pattern and complex signaling make somatostatin be such an extraordinary neurotransmitter and hormone. The potent inhibitory action of SSTR on cellular processes such as secretion, proliferation, and apoptosis is the reason for somatostatin to be the target for therapy development. Radiopharmaceuticals used for therapy consist of three parts: somatostatin analog, chelator, and radionuclide (alpha or beta-emitting). Combinations of different peptides, chelators, and radionuclides have been tested in vitro and/or in vivo for their use in peptide receptor radionuclide therapy (PRRT). These compounds are able to irradiate tumors and their metastases via the internalization through a specific receptor subtype which is generally overexpressed on the cell membrane.
Universitas Mataram
Title: Somatostatin
Description:
Somatostatin, also known as growth hormone-inhibiting factor (GIF) or somatotropin release-inhibiting factor (SRIF), is a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation.
Somatostatin can be regarded as secretory pan-inhibitory,because it can inhibit secretion of almost all endocrine and exocrine glands.
Somatostatin has 2 active forms (somatostatin-14 and 28), but the short half-life of the hormone was one of the reasons why the native hormone was not feasible for routine clinical practice.
Somatostatin analog was synthesized for the first time in 1980-1982 and proved to be more resistant to degradation and more potent than native hormone.
There are five somatostatin receptors (SSTR1-5).
The genes encoding human SSTR1-5 are located in chromosome 14q13, 17q24, 22q13.
1, 20p11.
2 and 16p13.
3.
SSTR expression pattern and complex signaling make somatostatin be such an extraordinary neurotransmitter and hormone.
The potent inhibitory action of SSTR on cellular processes such as secretion, proliferation, and apoptosis is the reason for somatostatin to be the target for therapy development.
Radiopharmaceuticals used for therapy consist of three parts: somatostatin analog, chelator, and radionuclide (alpha or beta-emitting).
Combinations of different peptides, chelators, and radionuclides have been tested in vitro and/or in vivo for their use in peptide receptor radionuclide therapy (PRRT).
These compounds are able to irradiate tumors and their metastases via the internalization through a specific receptor subtype which is generally overexpressed on the cell membrane.
Related Results
Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis
Effects of somatostatin, terlipressin and somatostatin plus terlipressin on portal and systemic hemodynamics and renal sodium excretion in patients with cirrhosis
AbstractBackground and Aim: Terlipressin and somatostatin are the most preferable agents for the control of variceal bleeding in cirrhotic patients. The present study evaluated th...
Differential Somatostatin Sensitivity of Corticotropic and Somatotropic Responses Following Amino Acid Infusion
Differential Somatostatin Sensitivity of Corticotropic and Somatotropic Responses Following Amino Acid Infusion
Abstract
Objective
Amino acids stimulate pituitary hormone secretion, but whether somatostatin-sensitive pathways differe...
Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus
Acute stress and dexamethasone rapidly increase hippocampal somatostatin synthesis and release from the dentate gyrus hilus
AbstractSomatostatin is a neuropeptide whose facilitatory action in the generation of long‐term potentiation (LTP) in the hippocampal dentate gyrus has been associated with memory ...
Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes
Effects of somatostatin, curcumin, and quercetin on the fatty acid profile of breast cancer cell membranes
Breast cancer is a worldwide commonly found malignancy in women and effective treatment is regarded as a huge clinical challenge even in the presence of several treatment options. ...
Androgenic control of immunoreactive somatostatin in the Harderian gland of the Syrian hamster
Androgenic control of immunoreactive somatostatin in the Harderian gland of the Syrian hamster
Summary. Harderian glands of Syrian hamsters contained measurable levels of immunoreactive somatostatin. After an extraction procedure, serial dilutions of tissue were assayed and ...
Gastrin, somatostatin and infantile hypertrophic pyloric stenosis
Gastrin, somatostatin and infantile hypertrophic pyloric stenosis
Despite multiple and often contradictory research, no firm conclusions regarding the role of hypergastrinaemia in infantile hypertrophic pyloric stenosis (IHPS) have been establish...
Glycine-extended gastrin enhances somatostatin release from cultured rabbit fundic D-cells
Glycine-extended gastrin enhances somatostatin release from cultured rabbit fundic D-cells
The role of the peptide hormone gastrin in stimulating gastric acid secretion is well established. Mature amidated gastrin is processed from larger peptide precursor forms. Increas...
Glutamate Peripherally Administered Exerts Somatostatin‐Releasing Action in the Conscious Rat
Glutamate Peripherally Administered Exerts Somatostatin‐Releasing Action in the Conscious Rat
AbstractThis study was designed to determine whether glutamate is able to stimulate somatostatin release from in vivo conscious animals when somatostatin release is monitored in un...

